Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity
Andrea Santamato(University of Foggia), Pietro Fiore(University of Foggia), Alessandro Picelli(University of Verona), Nicola Smania(University of Verona), Chiara Ciritella(University of Foggia), Alessio Baricich(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Nicoletta Cinone(University of Foggia), Giulio Gasperini(Ospedale Valduce), Stefania Spina(University of Foggia), Salvatore Facciorusso(Humanitas University), Luigi Santoro(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Franco Molteni(Bambino Gesù Children's Hospital), Christian Avvantaggiato(University of Foggia)
Cited by 27
Related Papers
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
|Journal of Hepatology|2020|361
Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
|BioMed Research International|2017|325
Posterior Reconstruction of the Rhabdosphincter Allows a Rapid Recovery of Continence after Transperitoneal Videolaparoscopic Radical Prostatectomy
|European Urology|2006|294
Rehabilitation procedures in the management of spasticity.
|PubMed|2010|168